» Authors » Pablo A Gonzalez

Pablo A Gonzalez

Explore the profile of Pablo A Gonzalez including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 132
Citations 2597
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Soto-Machuca A, Ortiz G, Carbone-Schellman J, Pasten-Ferrada I, Retamal-Diaz A, Kalergis A, et al.
mBio . 2025 Mar; :e0029125. PMID: 40035535
Herpesviruses are enveloped viruses with large double-stranded DNA genomes that are highly prevalent in the human population and elicit numerous types of clinical manifestations, from mild to severe. These viruses...
2.
Duarte L, Carbone-Schellman J, Bueno S, Kalergis A, Riedel C, Gonzalez P
Clin Microbiol Rev . 2025 Feb; 38(1):e0014724. PMID: 39982077
SUMMARYAntivirals play important roles in restricting viral diseases. Nevertheless, they act on a relatively limited number of viruses and occasionally display partial effectiveness in some tissues or against escape variants....
3.
Gonzalez-Madrid E, Rangel-Ramirez M, Opazo M, Mendez L, Bohmwald K, Bueno S, et al.
Front Endocrinol (Lausanne) . 2024 Dec; 15:1527177. PMID: 39726846
[This corrects the article DOI: 10.3389/fendo.2024.1381180.].
4.
Loaiza R, Farias M, Andrade C, Ramirez M, Rodriguez-Guilarte L, Munoz J, et al.
Expert Rev Anti Infect Ther . 2024 Sep; 22(8):631-645. PMID: 39269198
Introduction: The human respiratory syncytial virus (hRSV) is one of childhood diseases' most common respiratory pathogens and is associated with lower respiratory tract infections. The peak in disease that this...
5.
Yang W, Gonzalez P, Xin Q, Reyes M, Villalobos R, Borja-Tabora C, et al.
Vaccines (Basel) . 2024 Aug; 12(8). PMID: 39204018
Objectives: In this study, we aimed to evaluate the non-inferiority of a quadrivalent influenza vaccine (QIV) developed by Sinovac Biotech Co., Ltd. (Sinovac, Beijing, China) by comparing its immunogenicity and...
6.
Ramirez M, Loaiza R, Martinez-Balboa Y, Bruneau N, Ramirez E, Gonzalez P, et al.
Vaccine . 2024 Aug; 42(23):126203. PMID: 39178767
Methods: BALB/c mice were immunized with rBCG-N-SARS-CoV-2 and recombinant SARS-CoV-2 proteins in Alum adjuvant, followed by a booster with recombinant proteins to assess the safety and virus-specific cellular and humoral...
7.
Troncoso-Bravo T, Ramirez M, Loaiza R, Roman-Cardenas C, Papazisis G, Garrido D, et al.
Immunology . 2024 Aug; 173(3):481-496. PMID: 39161170
Acute respiratory infections are the leading cause of death and illness in children under 5 years old and represent a significant burden in older adults. Primarily caused by viruses infecting...
8.
Duarte L, Villalobos V, Farias M, Rangel-Ramirez M, Gonzalez-Madrid E, Navarro A, et al.
Commun Biol . 2024 Jul; 7(1):811. PMID: 38965360
Experimental autoimmune encephalomyelitis (EAE) is a demyelinating disease affecting the central nervous system (CNS) in animals that parallels several clinical and molecular traits of multiple sclerosis in humans. Herpes simplex...
9.
Carvajal J, Garcia-Castillo V, Cuellar S, Campillay-Veliz C, Salazar-Ardiles C, Avellaneda A, et al.
Front Immunol . 2024 Jun; 15:1363572. PMID: 38911850
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the respiratory distress condition known as COVID-19. This disease broadly affects several physiological systems, including the gastrointestinal, renal, and central...
10.
Rivera-Perez D, Mendez C, Diethelm-Varela B, Melo-Gonzalez F, Vazquez Y, Meng X, et al.
Front Immunol . 2024 May; 15:1372193. PMID: 38812507
Background: Vaccine effectiveness against SARS-CoV-2 infection has been somewhat limited due to the widespread dissemination of the Omicron variant, its subvariants, and the immune response dynamics of the naturally infected...